Can anticytokine therapy prevent unfavourable course of ulcerative colitis?
Aim of investigation. To study potential of tumor necrosis factor-alpha inhibitor Remicade to prevent complications and unfavorable course of ulcerative colitis.Material and methods. Therapeutic role of Remicade was investigated in one of three compared groups (24 patients) with unfavourable prognos...
Saved in:
Main Authors: | A. Yu. Baranovsky, E. A. Kondrashina, A. G. Kharitonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2013-12-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1251 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
by: A. Yu. Baranovsky, et al.
Published: (2012-06-01) -
Application of morphological criteria for definition of management approach for child with ulcerative colitis
by: E. N. Fedulova, et al.
Published: (2012-07-01) -
Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01) -
Serum cytokines in ulcerative colitis of various clinical activity
by: Ye. A. Konovich, et al.
Published: (2014-10-01) -
Mesalazine use tactics in the ulcerative colitis patients
by: A. V. Korolev, et al.
Published: (2013-03-01)